Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Weekly Azathioprine Pulse therapy is more effective than Betamethasone Oral Mini-Pulse for hair regrowth in moderate to severe Alopecia Areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Combining treatments works best for early hair loss, while transplants are best for severe cases.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

More severe alopecia areata can lower quality of life.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Botox injections may be a safe and effective way to treat severe, itchy skin disease when other treatments fail.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Azathioprine may help treat severe alopecia areata, but more research is needed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.